Life Sciences
This week's top stories include providers looking for an extension of the pandemic public health emergency to prep for the end of waivers and flexibilities, and a study finds that using Akili's video game-like intervention led to improved sustained attention.
The study did not find find a significant difference in depression symptoms between the intervention and control group.
It initially offers medicines and other healthcare products and services from over 500 independent sellers.
A new study published in the Lancet found that patients using VR therapy had a significant reduction in agoraphobic avoidance and distress compared to participants receiving usual care.
The company said it will use the financing to expand in Europe and the U.S., and develop new digital therapeutics with its pharma partners.
The multiyear agreement will focus on speeding clinical trials and drug development in oncology and nonalcoholic steatohepatitis.
The partnership, which includes Anthem, Biogen, Eli Lilly, Evidation, Janssen and Merck, gives payers guidance for including digital endpoints in reimbursement for new drugs.
Boots UK & Ireland CIO Rich Corbridge explores how the COVID-19 pandemic transformed clinician and patient attitudes toward technology.
The Series C comes about two years after another $150 million raise.
The algorithm analyses EHR data and learns treatment patterns of type 2 diabetes patients.